Laboratory Testing for Hepatocellular Liver Enzyme Elevation
Order a core liver aetiology panel including hepatitis B surface antigen (HBsAg), hepatitis C antibody, immunoglobulin G (IgG), autoantibodies (ANA, ASMA, anti-LKM), ferritin with transferrin saturation, and fasting glucose/lipid panel to identify treatable causes of hepatocellular injury. 1
Initial Core Laboratory Panel
The British Society of Gastroenterology recommends a standardized core panel as the first-line investigation for hepatocellular enzyme elevation 1:
- Viral hepatitis serologies: HBsAg, hepatitis B core IgM, and HCV antibody to identify viral causes 1, 2
- Autoimmune markers: Serum IgG and autoantibodies (antinuclear antibody, anti-smooth muscle antibody, anti-liver-kidney microsomal antibody) to detect autoimmune hepatitis 1
- Iron studies: Ferritin and transferrin saturation (>45% suggests hemochromatosis) 1
- Metabolic parameters: Fasting glucose, lipid panel, and assessment for metabolic syndrome components (obesity, diabetes, hypertension) to evaluate for nonalcoholic fatty liver disease 2
- Complete liver panel: AST, ALT, alkaline phosphatase, total and direct bilirubin, albumin, and prothrombin time to assess synthetic function 2
Additional Testing Based on Clinical Context
For Marked Elevations (ALT >1000 U/L)
Consider additional viral serologies including hepatitis A, hepatitis E, and cytomegalovirus 1
Extended Panel for Unclear Etiology
Reserve extended testing for patients without a clear cause after core panel 1:
- Thyroid function tests to rule out thyroid disorders as a cause of transaminase elevations 2
- Creatine kinase to exclude muscle disorders as a source of AST elevation 2
- Ceruloplasmin and 24-hour urinary copper if Wilson's disease is suspected (particularly in patients <40 years)
Key Diagnostic Considerations
Do not simply repeat the same liver enzyme panel without investigating the underlying cause, as 84% of abnormal tests remain elevated at 1 month and 75% at 2 years 1. The goal is etiologic diagnosis, not monitoring alone.
Pattern Recognition
- AST:ALT ratio <1 suggests NAFLD, viral hepatitis, or medication-induced injury 2
- AST:ALT ratio >2 suggests alcoholic liver disease 2
- Normal albumin, bilirubin, and PT/INR indicates preserved synthetic function despite hepatocellular injury 2
Common Pitfalls to Avoid
- Isolated elevated ferritin does not indicate hemochromatosis; it commonly occurs in dysmetabolic iron overload syndrome associated with alcohol excess and NAFLD 1. Transferrin saturation >45% is required for hemochromatosis diagnosis 1
- AST is less liver-specific than ALT and can be elevated in cardiac, skeletal muscle, kidney, and red blood cell disorders 2
- Normal ALT ranges differ by sex: 29-33 IU/L for males and 19-25 IU/L for females 2
Clinical History Requirements
Obtain specific details on 1:
- Alcohol consumption: Current and past intake in average units per week (consider AUDIT-C questionnaire) 1
- Comprehensive medication review: Prescribed, over-the-counter, herbal supplements, and illicit drug use 1, 2
- Metabolic syndrome features: Central obesity, hypertension, diabetes/insulin resistance, dyslipidemia 1
- Risk factors for viral hepatitis: Country of birth (strongest predictor of viral hepatitis), ethnicity, travel history, occupational exposure 1
- Symptoms: Jaundice, abdominal pain, weight loss, pruritus, fatigue 1
Imaging Recommendations
Abdominal ultrasound with Doppler is the initial imaging modality of choice for hepatocellular enzyme elevation 1, 2:
- Sensitivity of 84.8% and specificity of 93.6% for detecting moderate to severe hepatic steatosis 2
- Identifies structural causes including focal lesions, vascular abnormalities, and hepatosplenomegaly 2
- Doppler provides hemodynamic information when vascular abnormalities are suspected 1
For mild aminotransferase elevations, ultrasound and Doppler are complementary procedures that should be ordered together 1. For moderate to severe elevations, consider adding CT abdomen/pelvis with IV contrast 1.
Referral Criteria
Immediate specialist referral is warranted for 1:
- Unexplained clinical jaundice
- Suspicion of hepatic or biliary malignancy
- Evidence of hepatitis B (HBsAg positive), HCV (antibody and PCR positive), autoimmune hepatitis (raised IgG with positive autoantibodies), or hemochromatosis (ferritin elevated with transferrin saturation >45%)
- Dilated bile ducts on imaging requiring urgent assessment
Consider hepatology referral if transaminases remain elevated for ≥6 months without identified cause or if there is evidence of synthetic dysfunction 2.